Pérez Valero, I., Cabello Úbeda, A., Ryan, P., Fuente Moral, S. d. l., Santos Gil, I. d. l., Vivancos, M. J., . . . Górgolas Hernández-Mora, M. (2020). Randomized trial evaluating the neurotoxicity of dolutegravir/abacavir/lamivudine and Its reversibility after switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide: GESIDA 9016.
Citação norma ChicagoPérez Valero, Ignacio, et al. Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/abacavir/lamivudine and Its Reversibility After Switching to Elvitegravir/cobicistat/emtricitabine/tenofovir Alafenamide: GESIDA 9016. 2020.
Citação norma MLAPérez Valero, Ignacio, et al. Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/abacavir/lamivudine and Its Reversibility After Switching to Elvitegravir/cobicistat/emtricitabine/tenofovir Alafenamide: GESIDA 9016. 2020.